Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Major Manufacturers Covered in This Report
• 1.3 Market Segment by Type
  • 1.3.1 Global Antifungal Therapeutics Market Size Growth Rate by Type (2019-2025)
  • 1.3.2 Echinacea
  • 1.3.3 Polyene
  • 1.3.4 Pyrimidines
  • 1.3.5 Other
• 1.4 Market Segment by Application
  • 1.4.1 Global Antifungal Therapeutics Market Share by Application (2019-2025)
  • 1.4.2 Hospital
  • 1.4.3 Clinic
• 1.5 Study Objectives
• 1.6 Years Considered

2 Global Growth Trends

• 2.1 Global Antifungal Therapeutics Market Size
  • 2.1.1 Global Antifungal Therapeutics Revenue 2014-2025
  • 2.1.2 Global Antifungal Therapeutics Sales 2014-2025
• 2.2 Antifungal Therapeutics Growth Rate by Regions
  • 2.2.1 Global Antifungal Therapeutics Sales by Regions 2014-2019
  • 2.2.2 Global Antifungal Therapeutics Revenue by Regions 2014-2019
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers

3 Market Share by Manufacturers

• 3.1 Antifungal Therapeutics Sales by Manufacturers
  • 3.1.1 Antifungal Therapeutics Sales by Manufacturers 2014-2019
  • 3.1.2 Antifungal Therapeutics Sales Market Share by Manufacturers 2014-2019
• 3.2 Revenue by Manufacturers
  • 3.2.1 Antifungal Therapeutics Revenue by Manufacturers (2014-2019)
  • 3.2.2 Antifungal Therapeutics Revenue Share by Manufacturers (2014-2019)
  • 3.2.3 Global Antifungal Therapeutics Market Concentration Ratio (CR5 and HHI)
• 3.3 Antifungal Therapeutics Price by Manufacturers
• 3.4 Key Manufacturers Antifungal Therapeutics Plants/Factories Distribution and Area Served
• 3.5 Date of Key Manufacturers Enter into Antifungal Therapeutics Market
• 3.6 Key Manufacturers Antifungal Therapeutics Product Offered
• 3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Sales and Revenue for Each Type
  • 4.1.1 Echinacea Sales and Revenue (2014-2019)
  • 4.1.2 Polyene Sales and Revenue (2014-2019)
  • 4.1.3 Pyrimidines Sales and Revenue (2014-2019)
  • 4.1.4 Other Sales and Revenue (2014-2019)
• 4.2 Global Antifungal Therapeutics Sales Market Share by Type
• 4.3 Global Antifungal Therapeutics Revenue Market Share by Type
• 4.4 Antifungal Therapeutics Price by Type

5 Market Size by Application

• 5.1 Overview
• 5.2 Global Antifungal Therapeutics Sales by Application

6 United States

• 6.1 United States Antifungal Therapeutics Breakdown Data by Company
• 6.2 United States Antifungal Therapeutics Breakdown Data by Type
• 6.3 United States Antifungal Therapeutics Breakdown Data by Application

7 European Union

• 7.1 European Union Antifungal Therapeutics Breakdown Data by Company
• 7.2 European Union Antifungal Therapeutics Breakdown Data by Type
• 7.3 European Union Antifungal Therapeutics Breakdown Data by Application

8 China

• 8.1 China Antifungal Therapeutics Breakdown Data by Company
• 8.2 China Antifungal Therapeutics Breakdown Data by Type
• 8.3 China Antifungal Therapeutics Breakdown Data by Application

9 Rest of World

• 9.1 Rest of World Antifungal Therapeutics Breakdown Data by Company
• 9.2 Rest of World Antifungal Therapeutics Breakdown Data by Type
• 9.3 Rest of World Antifungal Therapeutics Breakdown Data by Application
• 9.4 Rest of World Antifungal Therapeutics Breakdown Data by Countries
  • 9.4.1 Rest of World Antifungal Therapeutics Sales by Countries
  • 9.4.2 Rest of World Antifungal Therapeutics Revenue by Countries
  • 9.4.3 Japan
  • 9.4.4 Korea
  • 9.4.5 India
  • 9.4.6 Southeast Asia

10 Company Profiles

• 10.1 Pfizer
  • 10.1.1 Pfizer Company Details
  • 10.1.2 Company Description and Business Overview
  • 10.1.3 Sales, Revenue and Market Share of Antifungal Therapeutics
  • 10.1.4 Antifungal Therapeutics Product Introduction
  • 10.1.5 Pfizer Recent Development
• 10.2 Merck
  • 10.2.1 Merck Company Details
  • 10.2.2 Company Description and Business Overview
  • 10.2.3 Sales, Revenue and Market Share of Antifungal Therapeutics
  • 10.2.4 Antifungal Therapeutics Product Introduction
  • 10.2.5 Merck Recent Development
• 10.3 GSK
  • 10.3.1 GSK Company Details
  • 10.3.2 Company Description and Business Overview
  • 10.3.3 Sales, Revenue and Market Share of Antifungal Therapeutics
  • 10.3.4 Antifungal Therapeutics Product Introduction
  • 10.3.5 GSK Recent Development
• 10.4 Novartis
  • 10.4.1 Novartis Company Details
  • 10.4.2 Company Description and Business Overview
  • 10.4.3 Sales, Revenue and Market Share of Antifungal Therapeutics
  • 10.4.4 Antifungal Therapeutics Product Introduction
  • 10.4.5 Novartis Recent Development
• 10.5 Roche
  • 10.5.1 Roche Company Details
  • 10.5.2 Company Description and Business Overview
  • 10.5.3 Sales, Revenue and Market Share of Antifungal Therapeutics
  • 10.5.4 Antifungal Therapeutics Product Introduction
  • 10.5.5 Roche Recent Development
• 10.6 Sanofi
  • 10.6.1 Sanofi Company Details
  • 10.6.2 Company Description and Business Overview
  • 10.6.3 Sales, Revenue and Market Share of Antifungal Therapeutics
  • 10.6.4 Antifungal Therapeutics Product Introduction
  • 10.6.5 Sanofi Recent Development
• 10.7 Johnson & Johnson
  • 10.7.1 Johnson & Johnson Company Details
  • 10.7.2 Company Description and Business Overview
  • 10.7.3 Sales, Revenue and Market Share of Antifungal Therapeutics
  • 10.7.4 Antifungal Therapeutics Product Introduction
  • 10.7.5 Johnson & Johnson Recent Development
• 10.8 Bayer
  • 10.8.1 Bayer Company Details
  • 10.8.2 Company Description and Business Overview
  • 10.8.3 Sales, Revenue and Market Share of Antifungal Therapeutics
  • 10.8.4 Antifungal Therapeutics Product Introduction
  • 10.8.5 Bayer Recent Development
• 10.9 Bristol-Myers Squibb
  • 10.9.1 Bristol-Myers Squibb Company Details
  • 10.9.2 Company Description and Business Overview
  • 10.9.3 Sales, Revenue and Market Share of Antifungal Therapeutics
  • 10.9.4 Antifungal Therapeutics Product Introduction
  • 10.9.5 Bristol-Myers Squibb Recent Development
• 10.10 AbbVie
  • 10.10.1 AbbVie Company Details
  • 10.10.2 Company Description and Business Overview
  • 10.10.3 Sales, Revenue and Market Share of Antifungal Therapeutics
  • 10.10.4 Antifungal Therapeutics Product Introduction
  • 10.10.5 AbbVie Recent Development
• 10.11 Eli Lilly
• 10.12 Actavis
• 10.13 Astellas
• 10.14 Teva

11 Value Chain and Sales Channels Analysis

• 11.1 Value Chain Analysis
• 11.2 Sales Channels Analysis
  • 11.2.1 Antifungal Therapeutics Sales Channels
  • 11.2.2 Antifungal Therapeutics Distributors
• 11.3 Antifungal Therapeutics Customers

12 Market Forecast

• 12.1 Global Antifungal Therapeutics Sales and Revenue Forecast 2019-2025
• 12.2 Global Antifungal Therapeutics Sales Forecast by Type
• 12.3 Global Antifungal Therapeutics Sales Forecast by Application
• 12.4 Antifungal Therapeutics Forecast by Regions
  • 12.4.1 Global Antifungal Therapeutics Sales Forecast by Regions 2019-2025
  • 12.4.2 Global Antifungal Therapeutics Revenue Forecast by Regions 2019-2025
• 12.5 United States Market Forecast
• 12.6 European Union Market Forecast
• 12.7 China Market Forecast
• 12.8 Rest of World
  • 12.8.1 Japan
  • 12.8.2 Korea
  • 12.8.3 India

13 Research Findings and Conclusion

14 Appendix

• 14.1 Research Methodology
  • 14.1.1 Methodology/Research Approach
    • 14.1.1.1 Research Programs/Design
    • 14.1.1.2 Market Size Estimation
    • 14.1.1.3 Market Breakdown and Data Triangulation
  • 14.1.2 Data Source
    • 14.1.2.1 Secondary Sources
    • 14.1.2.2 Primary Sources
• 14.2 Author Details

In 2019, the market size of Antifungal Therapeutics is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Antifungal Therapeutics.

This report studies the global market size of Antifungal Therapeutics, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Antifungal Therapeutics sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
Pfizer
Merck
GSK
Novartis
Roche
Sanofi
Johnson & Johnson
Bayer
Bristol-Myers Squibb
AbbVie
Eli Lilly
Actavis
Astellas
Teva

Market Segment by Product Type
Echinacea
Polyene
Pyrimidines
Other

Market Segment by Application
Hospital
Clinic

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the Antifungal Therapeutics status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Antifungal Therapeutics manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Antifungal Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025